Single-domain antibodies efficiently neutralize SARS-CoV-2 variants of concern, including Omicron variant
I. A. Favorskaya, D. V. Shcheblyakov, I. B. Esmagambetov, I. V. Dolzhikova, I. A. Alekseeva, A. I. Korobkova, D. V. Voronina, E. I. Ryabova, A. A. Derkaev, A. V. Kovyrshina, A. A. Iliukhina, A. G. Botikov, O. L. Voronina, D. A. Egorova, O. V. Zubkova, , A. L. Gintsburg
The paper identifies single-domain antibodies that neutralize SARS-CoV-2 variants, including Omicron, with enhanced potency through dimeric modifications.
bioRxiv · Nov 24, 2021 · PreprintImmunology